发明名称 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
摘要 A compound represented by the formula: (wherein, R<SUP>1 </SUP>and R<SUP>2 </SUP>are the same or different and each represents a hydrogen atom, hydrocarbon group or heterocyclic group, or R<SUP>1 </SUP>and R<SUP>2 </SUP>may form, together with the adjacent carbon atom, a 3-8 membered iso- or heterocyclic group, R<SUP>3 </SUP>represents a cyclic group, a hydroxy group, a mercapto group that may have oxo, or an amino group, R<SUP>4 </SUP>represents a hydrogen atom, a hydrocarbon group, a hydroxy group, a mercapto group which may have oxo, or an amino group, or R<SUP>2 </SUP>and R<SUP>4 </SUP>may link together to form a double bond, X represents a bond or a linear hydrocarbon group, W represents an oxygen atom or a sulfur atom, ring B represents a 5-8 membered nitrogen-containing heterocyclic group, ring C represents a benzene ring, and- represents a single bond or a double bond), or a salt or a prodrug thereof that has excellent neurodegenerative inhibitory activity and brain penetrability, and is useful as an agent for preventing/treating neurodegenerative diseases.
申请公布号 US7208495(B2) 申请公布日期 2007.04.24
申请号 US20030481367 申请日期 2003.12.18
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 OHKAWA SHIGENORI;MIYAMOTO MASAOMI;OKURA MASAHIRO;TSUKAMOTO TETSUYA
分类号 A61K31/497;A61K31/445;A61K31/4525;A61K31/496;A61P25/00;A61P25/14;A61P25/16;A61P25/22;A61P25/24;A61P25/28;A61P43/00;C07D307/79;C07D307/80;C07D307/81;C07D307/82;C07D307/83;C07D401/00;C07D405/00;C07D405/04;C07D405/12;C07D405/14;C07D407/04;C07D409/04;C07D409/14 主分类号 A61K31/497
代理机构 代理人
主权项
地址